These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 880799)

  • 1. The biological effects of a new modified sequential oral contraceptive.
    Widholm O; Alapiessa U
    Contraception; 1977 Jan; 15(1):1-13. PubMed ID: 880799
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced platelet aggregation by oral contraceptives: effect of PG synthetase inhibitors.
    Sudhir S; Gupta LC; Singh J; Garg KN
    Indian J Physiol Pharmacol; 1982; 26(3):231-4. PubMed ID: 6816736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects, on the endometrium, of a new oral contraceptive: Physiostat].
    Delacroix P
    Rev Fr Gynecol Obstet; 1977; 72(7-9):583-5. PubMed ID: 905717
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes of serum hormone concentrations during oral contraception using monohormonal and combination preparations (proceedings)].
    Nevinny-Stickel J; Schmidt-Gollwitzer M
    Arch Gynakol; 1977 Jul; 224(1-4):27-9. PubMed ID: 579816
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of a new combination oral contraceptive: lynestrenol-mestranol (Lyndiol).
    Moses LE; Goldzieher JW; Moses IG
    Fertil Steril; 1969; 20(5):715-28. PubMed ID: 5822858
    [No Abstract]   [Full Text] [Related]  

  • 6. [Insulin and proinsulin secretion under contraceptive steroid administration (author's transl)].
    Hausmann L; Goebel KM; Klähn D; Kaffarnik H
    Klin Wochenschr; 1975 Sep; 53(18):853-60. PubMed ID: 1165627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives according to the normophasic principle.
    Borglin NE; Klottrup P
    Arzneimittelforschung; 1978; 28(12):2354-7. PubMed ID: 582954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormonal tissue concentration and oral contraceptives: the endometrium].
    Carranco López A; Sojo Aranda I; Alonso Uriarte R; Castañeda Peña G; Bedolla Tovar N; Navarrete Arellano M; Cortés Gallegos V
    Ginecol Obstet Mex; 1979 Apr; 45(270):329-47. PubMed ID: 456926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new oral contraceptive with a 7 plus 15 sequential formulation.
    Brosens I; Van Assche A; Wijnants P
    Arzneimittelforschung; 1970 Feb; 20(2):236-7. PubMed ID: 5467468
    [No Abstract]   [Full Text] [Related]  

  • 10. Low dose lynestrenol as a contraceptive influence on ovarian function.
    Järvinen PA; Ylikorkala O; Ylöstalo P
    Ann Clin Res; 1974 Apr; 6(2):109-14. PubMed ID: 4837883
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electronenmicroscopic observation of the human endometrium under influence of inhibitors of ovulation with simultaneous oestrogen- and gestagen activity].
    Verhagen A; Themann H
    Arch Gynakol; 1970 Aug; 209(2):162-74. PubMed ID: 4103365
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of various contraceptive hormonal therapies in women with normal and diabetic oral glucose tolerance test.
    Aznar R; Lara R; Zarco D; González L
    Contraception; 1976 Mar; 13(3):299-311. PubMed ID: 55331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
    Odlind V; Weiner E; Victor A; Johansson ED
    Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovanon. A new sequential oral contraceptive.
    Rice-Wray E; Peña A; Maqueo M
    Int J Fertil; 1968; 13(4):453-9. PubMed ID: 5700405
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic effects of oral contraceptives during exercise.
    Lehtovirta P; Kuikka J; Pyörälä T
    Int J Gynaecol Obstet; 1977; 15(1):35-7. PubMed ID: 923890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical aspects of a new, very low dose combination contraceptive].
    Mladenović D; Grcić R; Pestelek B; Kapor M
    Fortschr Med; 1978 Apr; 96(13):723-6. PubMed ID: 631715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central and peripheral actions of an oral contraceptive with reduced oestrogen content (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1977 Apr; 89(9):311-3. PubMed ID: 855349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum prostaglandin F levels during menstrual cycle in women using oral contraceptives.
    Garg SK
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):431-2. PubMed ID: 6629547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
    Lalos O; Joelsson I
    Acta Obstet Gynecol Scand; 1981; 60(3):229-32. PubMed ID: 7270089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.